- Home
- AL vs RARE Comparison
AL vs RARE Comparison
Compare AL & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AL
- RARE
- Stock Information
- Founded
- AL 2010
- RARE 2010
- Country
- AL United States
- RARE United States
- Employees
- AL N/A
- RARE N/A
- Industry
- AL Diversified Commercial Services
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- AL Consumer Discretionary
- RARE Health Care
- Exchange
- AL Nasdaq
- RARE Nasdaq
- Market Cap
- AL 5.2B
- RARE 5.2B
- IPO Year
- AL 2011
- RARE 2014
- Fundamental
- Price
- AL $49.08
- RARE $44.95
- Analyst Decision
- AL Strong Buy
- RARE Strong Buy
- Analyst Count
- AL 5
- RARE 14
- Target Price
- AL $57.20
- RARE $87.50
- AVG Volume (30 Days)
- AL 568.4K
- RARE 597.2K
- Earning Date
- AL 02-13-2025
- RARE 11-05-2024
- Dividend Yield
- AL 1.74%
- RARE N/A
- EPS Growth
- AL N/A
- RARE N/A
- EPS
- AL 4.39
- RARE N/A
- Revenue
- AL $2,737,330,000.00
- RARE $522,745,000.00
- Revenue This Year
- AL $3.69
- RARE $27.36
- Revenue Next Year
- AL $12.32
- RARE $18.61
- P/E Ratio
- AL $11.18
- RARE N/A
- Revenue Growth
- AL 6.51
- RARE 27.44
- 52 Week Low
- AL $39.15
- RARE $37.02
- 52 Week High
- AL $52.31
- RARE $60.37
- Technical
- Relative Strength Index (RSI)
- AL 49.07
- RARE 34.53
- Support Level
- AL $49.21
- RARE $48.29
- Resistance Level
- AL $49.99
- RARE $50.00
- Average True Range (ATR)
- AL 1.05
- RARE 1.59
- MACD
- AL -0.35
- RARE -0.07
- Stochastic Oscillator
- AL 10.14
- RARE 11.33
About AL Air Lease Corporation
Air Lease Corp is an aircraft leasing company based in the United States. However, it derives its revenue from the Asia region. Its business involves purchasing aircraft from renowned manufacturers such as The Boeing Company (Boeing) and Airbus S.A.S and leasing them to airline companies across the world. Its suite of aircraft entails single-aisle narrow-bodied jets and twin-aisle wide-bodied aircraft. The company earns from revenue originates from the renting of flight equipment. Geographically it operates in Asia Pacific, Europe, The Middle East and Africa, Central America, South America and Mexico and U.S. and Canada.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.